+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vonoprazan Fumarate Tablets Market - Global Forecast 2025-2030- Product Image
Vonoprazan Fumarate Tablets Market - Global Forecast 2025-2030- Product Image
Sale

Vonoprazan Fumarate Tablets Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6138963
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The vonoprazan fumarate tablet market is entering a critical phase, shaped by innovative acid suppression therapies, evolving regulatory dynamics, and strategic commercial shifts worldwide. Senior decision-makers require forward-looking insights to navigate a competitive landscape that demands agility, resilience, and targeted investment in market-shaping technologies.

Market Snapshot: Current Dynamics and Growth Potential for Vonoprazan Fumarate Tablets

The global market for vonoprazan fumarate tablets is advancing rapidly as healthcare providers and manufacturers focus on novel therapies to address unmet needs in acid-related gastrointestinal disorders. This segment is defined by robust interest from clinicians and life sciences companies, responding to vonoprazan’s differentiated pharmacological profile and swift adoption across various gastric indications. Ongoing regulatory approvals, strategic partnerships, and digital health integrations continue to support the accelerated market momentum observed on a worldwide scale.

Scope & Segmentation: Mapping the Vonoprazan Opportunity

This report delivers a rigorous analysis of the vonoprazan fumarate tablet market, categorizing growth opportunities by product, usage environment, and regional developments:

  • Distribution Channels: Hospital pharmacy, online pharmacy, retail pharmacy.
  • Treatment Indications: Gastroesophageal reflux disease, Helicobacter pylori eradication, peptic ulcer disease, duodenal ulcer, gastric ulcer.
  • Dosage Strengths: 10 milligram, 20 milligram, 40 milligram formulations.
  • Product Form: Immediate release and modified release tablets.
  • End User Environments: Clinics, home care settings, secondary hospitals, tertiary hospitals.
  • Geographies: Americas (notably United States, Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland); Asia-Pacific (led by China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Key Players: Takeda Pharmaceutical Company Limited, Phathom Pharmaceuticals, Inc., Dr. Reddy’s Laboratories Limited, Teva Pharmaceutical Industries Ltd., Viatris Inc., Sandoz International GmbH, Lupin Limited, Aurobindo Pharma Limited, Cipla Limited, Hetero Drugs Limited.

Key Takeaways: Strategic Insights for Decision-Makers

  • Vonoprazan’s potassium-competitive acid blocking mechanism offers a distinct mode of action versus proton pump inhibitors, supporting greater flexibility in managing patient response and adherence.
  • Regional adoption patterns highlight the necessity to tailor go-to-market strategies, as regulatory frameworks and payer dynamics differ widely between the Americas, Europe, Middle East & Africa, and Asia-Pacific.
  • Partnerships—between pharmaceutical manufacturers, contract manufacturing organizations, biotechnology firms, and specialty distributors—are intensifying as companies position themselves to achieve launch readiness, scale production, and optimize channel penetration.
  • Technological advances in digital health, including telemedicine platforms and remote patient monitoring, are enhancing real-world data capture and supporting broad clinical adoption.
  • Industry stakeholders are responding to evolving policy considerations by advancing payer engagement and developing evidence packages focused on patient-reported outcomes and holistic care improvements.

Tariff Impact: Navigating Trade Disruption in the U.S. Market

Recent U.S. trade tariffs introduced in 2025 have increased the cost of imported active pharmaceutical ingredients for vonoprazan fumarate tablets. As a result, manufacturers are reassessing supply chain strategies—many pivot to regional production bases in Europe and Asia-Pacific. This shift aims to mitigate increased duties and logistical challenges, while healthcare providers adapt to unpredictable procurement costs. Industry consortia are actively advocating for tariff exemptions in critical drug categories to stabilize supply and protect access for patients.

Methodology & Data Sources

This report employs a multi-method approach, integrating primary interviews with stakeholders such as gastroenterologists, procurement specialists, and regulatory advisors, alongside secondary research of journals, conference papers, and policy documents. Data triangulation, scenario planning, and sensitivity analysis underpin segmentation, competitive benchmarking, and trend projections.

Why This Report Matters: Actionable Intelligence for Senior Decision-Makers

  • Aligns operational and strategic priorities by clarifying evolving segment trends, payer frameworks, and competitive dynamics.
  • Equips commercial and clinical leaders with in-depth context to refine market entry, supply chain, and evidence generation strategies.
  • Provides a holistic perspective to anticipate disruption from regulatory, policy, and technological shifts across core regions.

Conclusion

The vonoprazan fumarate tablet market is set for transformation, driven by innovation in acid suppression therapy, responsive regulatory strategies, and globally adaptive supply chains. Proactive, data-driven planning remains a core success factor for market leadership.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Clinical trial expansion for Vonoprazan fumarate in H pylori eradication regimens
5.2. Strategic alliances between pharmaceutical companies to expand Vonoprazan distribution in Asia Pacific
5.3. Emerging gastroenterology guideline updates endorsing potassium competitive acid blockers usage
5.4. Pricing challenges from generic Vonoprazan fumarate tablets affecting profitability margins
5.5. Regulatory milestones for Vonoprazan approval in pediatric reflux esophagitis indication
5.6. Real world evidence studies highlighting improved patient adherence to Vonoprazan therapy
5.7. Comparative efficacy data influencing physician preference for Vonoprazan over proton pump inhibitors
5.8. Patient access program implementations and reimbursement landscape shaping market uptake
5.9. Development of fixed dose combinations including Vonoprazan and antibiotics for H pylori treatment
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Vonoprazan Fumarate Tablets Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacy
8.3. Online Pharmacy
8.4. Retail Pharmacy
9. Vonoprazan Fumarate Tablets Market, by Treatment Indication
9.1. Introduction
9.2. Gastroesophageal Reflux Disease
9.3. Helicobacter Pylori Eradication
9.4. Peptic Ulcer Disease
9.4.1. Duodenal Ulcer
9.4.2. Gastric Ulcer
10. Vonoprazan Fumarate Tablets Market, by Dosage Strength
10.1. Introduction
10.2. 10 Milligram
10.3. 20 Milligram
10.4. 40 Milligram
11. Vonoprazan Fumarate Tablets Market, by Product Form
11.1. Introduction
11.2. Tablet
11.2.1. Immediate Release
11.2.2. Modified Release
12. Vonoprazan Fumarate Tablets Market, by End User
12.1. Introduction
12.2. Clinic
12.3. Home Care
12.4. Hospital
12.4.1. Secondary Hospital
12.4.2. Tertiary Hospital
13. Americas Vonoprazan Fumarate Tablets Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Vonoprazan Fumarate Tablets Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Vonoprazan Fumarate Tablets Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Takeda Pharmaceutical Company Limited
16.3.2. Phathom Pharmaceuticals, Inc.
16.3.3. Dr. Reddy’s Laboratories Limited
16.3.4. Teva Pharmaceutical Industries Ltd.
16.3.5. Viatris Inc.
16.3.6. Sandoz International GmbH
16.3.7. Lupin Limited
16.3.8. Aurobindo Pharma Limited
16.3.9. Cipla Limited
16.3.10. Hetero Drugs Limited
17. Research AI18. Research Statistics19. Research Contacts20. Research Articles21. Appendix
List of Figures
FIGURE 1. VONOPRAZAN FUMARATE TABLETS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 6. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TREATMENT INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TREATMENT INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 10. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PRODUCT FORM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PRODUCT FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. VONOPRAZAN FUMARATE TABLETS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. VONOPRAZAN FUMARATE TABLETS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. VONOPRAZAN FUMARATE TABLETS MARKET: RESEARCHAI
FIGURE 26. VONOPRAZAN FUMARATE TABLETS MARKET: RESEARCHSTATISTICS
FIGURE 27. VONOPRAZAN FUMARATE TABLETS MARKET: RESEARCHCONTACTS
FIGURE 28. VONOPRAZAN FUMARATE TABLETS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. VONOPRAZAN FUMARATE TABLETS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TREATMENT INDICATION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TREATMENT INDICATION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HELICOBACTER PYLORI ERADICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HELICOBACTER PYLORI ERADICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DUODENAL ULCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DUODENAL ULCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY GASTRIC ULCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY GASTRIC ULCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY 10 MILLIGRAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY 10 MILLIGRAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY 20 MILLIGRAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY 20 MILLIGRAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY 40 MILLIGRAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY 40 MILLIGRAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY MODIFIED RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY MODIFIED RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY SECONDARY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY SECONDARY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TERTIARY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TERTIARY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TREATMENT INDICATION, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TREATMENT INDICATION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TREATMENT INDICATION, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TREATMENT INDICATION, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 99. CANADA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. CANADA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. CANADA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TREATMENT INDICATION, 2018-2024 (USD MILLION)
TABLE 102. CANADA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TREATMENT INDICATION, 2025-2030 (USD MILLION)
TABLE 103. CANADA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 104. CANADA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 105. CANADA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 106. CANADA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 107. CANADA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 108. CANADA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 109. CANADA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 110. CANADA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 111. CANADA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. CANADA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. CANADA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 114. CANADA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 115. MEXICO VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. MEXICO VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. MEXICO VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TREATMENT INDICATION, 2018-2024 (USD MILLION)
TABLE 118. MEXICO VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TREATMENT INDICATION, 2025-2030 (USD MILLION)
TABLE 119. MEXICO VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 120. MEXICO VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 121. MEXICO VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 122. MEXICO VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 123. MEXICO VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 124. MEXICO VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 125. MEXICO VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 126. MEXICO VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 127. MEXICO VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. MEXICO VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. MEXICO VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 130. MEXICO VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TREATMENT INDICATION, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TREATMENT INDICATION, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TREATMENT INDICATION, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TREATMENT INDICATION, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TREATMENT INDICATION, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TREATMENT INDICATION, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TREATMENT INDICATION, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TREATMENT INDICATION, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 197. GERMANY VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. GERMANY VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. GERMANY VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TREATMENT INDICATION, 2018-2024 (USD MILLION)
TABLE 200. GERMANY VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TREATMENT INDICATION, 2025-2030 (USD MILLION)
TABLE 201. GERMANY VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 202. GERMANY VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 203. GERMANY VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 204. GERMANY VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 205. GERMANY VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 206. GERMANY VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 207. GERMANY VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 208. GERMANY VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 209. GERMANY VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. GERMANY VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. GERMANY VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 212. GERMANY VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 213. FRANCE VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 214. FRANCE VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 215. FRANCE VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TREATMENT INDICATION, 2018-2024 (USD MILLION)
TABLE 216. FRANCE VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TREATMENT INDICATION, 2025-2030 (USD MILLION)
TABLE 217. FRANCE VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 218. FRANCE VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 219. FRANCE VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 220. FRANCE VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 221. FRANCE VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 222. FRANCE VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 223. FRANCE VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 224. FRANCE VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 225. FRANCE VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. FRANCE VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. FRANCE VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 228. FRANCE VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 229. RUSSIA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. RUSSIA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TREATMENT INDICATION, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TREATMENT INDICATION, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 245. ITALY VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. ITALY VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. ITALY VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TREATMENT INDICATION, 2018-2024 (USD MILLION)
TABLE 248. ITALY VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TREATMENT INDICATION, 2025-2030 (USD MILLION)
TABLE 249. ITALY VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 250. ITALY VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 251. ITALY VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 252. ITALY VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 253. ITALY VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 254. ITALY VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 255. ITALY VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 256. ITALY VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 257. ITALY VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. ITALY VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. ITALY VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 260. ITALY VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 261. SPAIN VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. SPAIN VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. SPAIN VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TREATMENT INDICATION, 2018-2024 (USD MILLION)
TABLE 264. SPAIN VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TREATMENT INDICATION, 2025-2030 (USD MILLION)
TABLE 265. SPAIN VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 266. SPAIN VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 267. SPAIN VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 268. SPAIN VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 269. SPAIN VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 270. SPAIN VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 271. SPAIN VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 272. SPAIN VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 273. SPAIN VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. SPAIN VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. SPAIN VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 276. SPAIN VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TREATMENT INDICATION, 2018-2024 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TREATMENT INDICATION, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. SAUDI ARABIA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TREATMENT INDICATION, 2018-2024 (USD MILLION)
TABLE 296. SAUDI ARABIA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TREATMENT INDICATION, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 309. SOUTH AFRICA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 310. SOUTH AFRICA VONOPRAZAN FUMARATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 311. SOU

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Vonoprazan Fumarate Tablets Market report include:
  • Takeda Pharmaceutical Company Limited
  • Phathom Pharmaceuticals, Inc.
  • Dr. Reddy’s Laboratories Limited
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Sandoz International GmbH
  • Lupin Limited
  • Aurobindo Pharma Limited
  • Cipla Limited
  • Hetero Drugs Limited

Related Topics

Related Reports

Peptic Ulcers Pipeline Analysis Report 2025 - Product Image

Peptic Ulcers Pipeline Analysis Report 2025

  • Report
  • 200 Pages
  • Global
From
Clarithromycin Tablets Global Market Report 2025 - Product Image

Clarithromycin Tablets Global Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Amoxicillin Market Report 2025 - Product Image

Amoxicillin Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Quetiapine Fumarate Tablets Market - Global Forecast 2025-2030 - Product Image

Quetiapine Fumarate Tablets Market - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Tenofovir Disoproxil Fumarate Tablets Market - Global Forecast to 2030 - Product Image

Tenofovir Disoproxil Fumarate Tablets Market - Global Forecast to 2030

  • Report
  • 185 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.